U.S. pharma large copyright scrapped two experimental weight loss supplements previous 12 months—a at the time-day by day tablet, lotiglipron, resulting from elevated liver enzymes and a two times-every day pill, danuglipron, as a consequence of strong Unintended effects—but CEO Albe